"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 22 | 22 |
| 1996 | 0 | 20 | 20 |
| 1997 | 0 | 11 | 11 |
| 1998 | 0 | 23 | 23 |
| 1999 | 0 | 18 | 18 |
| 2000 | 0 | 11 | 11 |
| 2001 | 0 | 24 | 24 |
| 2002 | 0 | 20 | 20 |
| 2003 | 0 | 28 | 28 |
| 2004 | 0 | 28 | 28 |
| 2005 | 0 | 39 | 39 |
| 2006 | 0 | 44 | 44 |
| 2007 | 0 | 41 | 41 |
| 2008 | 0 | 54 | 54 |
| 2009 | 0 | 41 | 41 |
| 2010 | 1 | 52 | 53 |
| 2011 | 0 | 76 | 76 |
| 2012 | 0 | 60 | 60 |
| 2013 | 1 | 67 | 68 |
| 2014 | 2 | 75 | 77 |
| 2015 | 0 | 71 | 71 |
| 2016 | 1 | 84 | 85 |
| 2017 | 1 | 96 | 97 |
| 2018 | 1 | 95 | 96 |
| 2019 | 2 | 86 | 88 |
| 2020 | 0 | 82 | 82 |
| 2021 | 0 | 39 | 39 |
| 2022 | 0 | 12 | 12 |
| 2023 | 0 | 13 | 13 |
| 2024 | 0 | 39 | 39 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2025 Feb 01; 151(2):113-120.
-
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):356-363.
-
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro Oncol. 2025 Jan 12; 27(1):89-105.
-
ASO Visual Abstract: Real-World Implications of the SOUND Trial. Ann Surg Oncol. 2025 Jan; 32(1):121-122.
-
Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
-
Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321. Pediatr Blood Cancer. 2025 Mar; 72(3):e31490.
-
Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma. Pediatr Blood Cancer. 2025 Mar; 72(3):e31477.
-
Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21-Year Retrospective Analysis of CDC-WONDER Database. Clin Cardiol. 2024 Dec; 47(12):e70058.
-
Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination. Ann Surg Oncol. 2025 Feb; 32(2):679-686.
-
CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol. 2025 Feb; 32(2):1021-1032.